A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

MLA

Shin Fujisawa, et al. “A Randomized Comparison of 4 Courses of Standard-Dose Multiagent Chemotherapy versus 3 Courses of High-Dose Cytarabine Alone in Postremission Therapy for Acute Myeloid Leukemia in Adults: The JALSG AML201 Study.” Blood, vol. 117, Feb. 2011, pp. 2366–72. EBSCOhost, https://doi.org/10.1182/blood-2010-07-295279.

APA

Shin Fujisawa, Norio Asou, Kazunori Ohnishi, Hitoshi Kiyoi, Atsushi Fujieda, Hisashi Sakamaki, Sumihisa Honda, Shigeki Ohtake, Noriko Usui, Yasushi Miyazaki, Yukihiko Kimura, Shuichi Miyawaki, Takahisa Yamane, Ryuzo Ohno, Tadashi Nagai, Toru Sakura, Chiaki Nakaseko, Masatomo Takahashi, Katsuji Shinagawa, … Tomoki Naoe. (2011). A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study. Blood, 117, 2366–2372. https://doi.org/10.1182/blood-2010-07-295279

Chicago

Shin Fujisawa, Norio Asou, Kazunori Ohnishi, Hitoshi Kiyoi, Atsushi Fujieda, Hisashi Sakamaki, Sumihisa Honda, et al. 2011. “A Randomized Comparison of 4 Courses of Standard-Dose Multiagent Chemotherapy versus 3 Courses of High-Dose Cytarabine Alone in Postremission Therapy for Acute Myeloid Leukemia in Adults: The JALSG AML201 Study.” Blood 117 (February): 2366–72. doi:10.1182/blood-2010-07-295279.